Advertisement

Journal of Molecular Neuroscience

, Volume 64, Issue 4, pp 574–580 | Cite as

Determining the Effect of the HNMT, STK39, and NMD3 Polymorphisms on the Incidence of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Multiple System Atrophy in Chinese Populations

  • Yongping Chen
  • Bei Cao
  • Ruwei Ou
  • Qianqian Wei
  • Xueping Chen
  • Bi Zhao
  • Ying Wu
  • Wei Song
  • Hui-Fang Shang
Article

Abstract

Large-scale meta-analyses of genome-wide association studies have identified several loci linked to sporadic Parkinson’s disease (PD). However, the roles of some important loci, such as HNMT Thr105Ile, STK39 rs2390669, and NMD3 rs34016896, have not been clarified in Chinese populations. Accumulating evidence indicates that some common clinicopathological characteristics are shared by different neurodegenerative diseases. Consequently, we conducted a large sample study to investigate associations between these variants and PD, multiple system atrophy (MSA), and amyotrophic lateral sclerosis (ALS) in Chinese populations. A total of 2417 patients, including 1237 PD, 850 SALS, and 330 MSA patients, along with 836 healthy controls (HCs) were examined in this study. All patients were genotyped for SNPs using the Sequenom iPLEX assay. No significant differences were found in the genotype and allele frequency distributions between the three neurodegenerative diseases and three candidate variants investigated. In subgroup analysis, compared with PD patients with initial symptom of tremor and HCs, the minor allele frequency of NMD3 rs34016896 in PD patients with initial symptoms of rigidity/bradykinesia was significantly lower. In addition, female patients carrying the rs34016896 minor allele had an increased risk of developing MSA (OR 1.25, 95% CI [1.09–1.43]), and ALS patients carrying the Ile105 polymorphism on the Thr105Ile allele in the HNMT gene exhibited a trend toward a delay in symptom onset of 3.010 ± 1.629 years. Our results indicate that the presence of the rs34016896 allele in the NMD3 gene may contribute to the development of synucleinopathies and that the Thr105Ile allele in the HNMT gene could potentially be an important therapeutic target for the treatment of ALS.

Keywords

Parkinson’s disease Amyotrophic lateral sclerosis Multiple system atrophy Variants Association analysis 

Notes

Acknowledgements

The authors thank all subjects for their participation in the study.

Funding Information

The present study was supported by funding from the National Science Fund of China (Grant Nos. 81571247 and 81701249) and the National Key Research and Development Program of China (Grant No. 2017YFC0909101).

Compliance with Ethical Standards

Ethical Approval

Signed informed consent forms were obtained from all subjects, and the study was approved by the Ethics Committee of Sichuan University (approval no.2015-236).

Competing Interests

The authors declare that they have no conflicts of interest.

Supplementary material

12031_2018_1048_MOESM1_ESM.docx (72 kb)
ESM 1 (DOCX 72 kb)

References

  1. Agundez JA, Luengo A, Herraez O, Martinez C, Alonso-Navarro H, Jimenez-Jimenez FJ, Garcia-Martin E (2008) Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease. NeuroMolecular Med 10:10–16.  https://doi.org/10.1007/s12017-007-8017-7 CrossRefPubMedGoogle Scholar
  2. Anichtchik OV, Rinne JO, Kalimo H, Panula P (2000) An altered histaminergic innervation of the substantia nigra in Parkinson’s disease. Exp Neurol 163:20–30.  https://doi.org/10.1006/exnr.2000.7362 CrossRefPubMedGoogle Scholar
  3. Brooks BR, Miller RG, Swash M, Munsat TL (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293–299CrossRefPubMedGoogle Scholar
  4. Buhlmann M et al (2015) NMD3 regulates both mRNA and rRNA nuclear export in African trypanosomes via an XPOI-linked pathway. Nucleic Acids Res 43:4491–4504.  https://doi.org/10.1093/nar/gkv330 CrossRefPubMedPubMedCentralGoogle Scholar
  5. Das K, Nag C, Ghosh M (2012) Familial, environmental, and occupational risk factors in development of amyotrophic lateral sclerosis. N Am J Med Sci 4:350–355.  https://doi.org/10.4103/1947-2714.99517 CrossRefPubMedPubMedCentralGoogle Scholar
  6. Davis AA, Andruska KM, Benitez BA, Racette BA, Perlmutter JS, Cruchaga C (2016) Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression. Neurobiol Aging 37:209 e201–209 e207.  https://doi.org/10.1016/j.neurobiolaging.2015.09.014 CrossRefGoogle Scholar
  7. Dupont WD, Plummer WD Jr (1990) Power and sample size calculations. A review and computer program. Control Clin Trials 11:116–128CrossRefPubMedGoogle Scholar
  8. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Durr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676.  https://doi.org/10.1212/01.wnl.0000324625.00404.15 CrossRefPubMedPubMedCentralGoogle Scholar
  9. Haas HL, Sergeeva OA, Selbach O (2008) Histamine in the nervous system. Physiol Rev 88:1183–1241.  https://doi.org/10.1152/physrev.00043.2007 CrossRefPubMedGoogle Scholar
  10. Hautbergue GM (2017) RNA nuclear export: from neurological disorders to cancer. Adv Exp Med Biol 1007:89–109.  https://doi.org/10.1007/978-3-319-60733-7_6 CrossRefPubMedGoogle Scholar
  11. Hernandez DG, Nalls MA, Ylikotila P, Keller M, Hardy JA, Majamaa K, Singleton AB (2012) Genome wide assessment of young onset Parkinson’s disease from Finland. PLoS One 7:e41859.  https://doi.org/10.1371/journal.pone.0041859 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (2001) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. 1992. Neurology 57:S34–S38CrossRefPubMedGoogle Scholar
  13. International Parkinson Disease Genomics C et al (2011) Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377:641–649.  https://doi.org/10.1016/S0140-6736(10)62345-8 CrossRefGoogle Scholar
  14. International Parkinson’s Disease Genomics C, Wellcome Trust Case Control C (2011) A two-stage meta-analysis identifies several new loci for Parkinson’s disease. PLoS Genet 7:e1002142.  https://doi.org/10.1371/journal.pgen.1002142 CrossRefGoogle Scholar
  15. Jansen IE et al (2017) Establishing the role of rare coding variants in known Parkinson’s disease risk loci. Neurobiol Aging 59:220 e211–220 e218.  https://doi.org/10.1016/j.neurobiolaging.2017.07.009 CrossRefGoogle Scholar
  16. Keeling BH, Vilariño-Güell C, Soto-Ortolaza AI, Ross OA, Uitti RJ, Rajput A, Wszolek ZK, Farrer MJ (2010) Histamine N-methyltransferase Thr105Ile is not associated with Parkinson’s disease or essential tremor. Parkinsonism Relat Disord 16:112–114.  https://doi.org/10.1016/j.parkreldis.2009.08.011 CrossRefPubMedGoogle Scholar
  17. Kovacs GG (2016) Molecular pathological classification of neurodegenerative diseases: turning towards precision medicine Int J Mol Sci 17(2). pii: E189.  https://doi.org/10.3390/ijms17020189
  18. Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BMM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP, 23andMe, The Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium, The International Parkinson's Disease Genomics Consortium (IPDGC), The Parkinson's Disease GWAS Consortium, The Wellcome Trust Case Control Consortium 2 (WTCCC2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JPA, Bertram L (2012) Comprehensive research synopsis and systematic meta-analyses in Parkinson’s disease genetics: the PDGene database. PLoS Genet 8:e1002548.  https://doi.org/10.1371/journal.pgen.1002548 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Liu ZH, Guo JF, Li K, Wang YQ, Kang JF, Wei Y, Sun QY, Xu Q, Wang DL, Xia K, Yan XX, Xu CS, Tang BS (2015) Analysis of several loci from genome-wide association studies in Parkinson’s disease in mainland China. Neurosci Lett 587:68–71.  https://doi.org/10.1016/j.neulet.2014.12.027 CrossRefPubMedGoogle Scholar
  20. McCulloch CC et al (2008) Exploring gene-environment interactions in Parkinson’s disease. Hum Genet 123:257–265.  https://doi.org/10.1007/s00439-008-0466-z CrossRefPubMedGoogle Scholar
  21. Palada V, Terzić J, Mazzulli J, Bwala G, Hagenah J, Peterlin B, Hung AY, Klein C, Krainc D (2012) Histamine N-methyltransferase Thr105Ile polymorphism is associated with Parkinson’s disease. Neurobiol Aging 33(836):e831–e833.  https://doi.org/10.1016/j.neurobiolaging.2011.06.015 Google Scholar
  22. Preuss CV, Wood TC, Szumlanski CL, Raftogianis RB, Otterness DM, Girard B, Scott MC, Weinshilboum RM (1998) Human histamine N-methyltransferase pharmacogenetics: common genetic polymorphisms that alter activity. Mol Pharmacol 53:708–717CrossRefPubMedGoogle Scholar
  23. Rinne JO, Anichtchik OV, Eriksson KS, Kaslin J, Tuomisto L, Kalimo H, Röyttä M, Panula P (2002) Increased brain histamine levels in Parkinson’s disease but not in multiple system atrophy. J Neurochem 81:954–960CrossRefPubMedGoogle Scholar
  24. Shulman JM, Yu L, Buchman AS, Evans DA, Schneider JA, Bennett DA, De Jager PL (2014) Association of Parkinson disease risk loci with mild parkinsonian signs in older persons. JAMA Neurol 71:429–435.  https://doi.org/10.1001/jamaneurol.2013.6222 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Wang YQ, Tang BS, Yu RL, Li K, Liu ZH, Xu Q, Sun QY, Yan XX, Guo JF (2014) Association analysis of STK39, MCCC1/LAMP3 and sporadic PD in the Chinese Han population. Neurosci Lett 566:206–209.  https://doi.org/10.1016/j.neulet.2014.03.007 CrossRefPubMedGoogle Scholar
  26. Wang L, Cheng L, Lu ZJ, Sun XY, Li JY, Peng R (2016) Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson’s disease in Han Chinese. J Neural Transm (Vienna) 123:425–430.  https://doi.org/10.1007/s00702-016-1526-5 CrossRefGoogle Scholar
  27. Wei Q, Chen X, Zheng Z, Huang R, Guo X, Cao B, Bak TH, Shang H (2015) Screening for cognitive impairment in a Chinese ALS population. Amyotroph Lateral Scler Frontotemporal Degener 16:40–45.  https://doi.org/10.3109/21678421.2014.966311 CrossRefPubMedGoogle Scholar
  28. Yang X, Liu C, Zhang J, Han H, Wang X, Liu Z, Xu Y (2015) Association of histamine N-methyltransferase Thr105Ile polymorphism with Parkinson’s disease and schizophrenia in Han Chinese: a case-control study. PLoS One 10:e0119692.  https://doi.org/10.1371/journal.pone.0119692 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Neurology, West China HospitalSichuan UniversityChengduChina

Personalised recommendations